Avoro Capital Advisors’s Cellectis CLLS Stock Holding History

Avoro Capital Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-78,289	Closed	-$2.28M	–	59
2017 Q4	$2.28M	Hold	78,289	–	–	0.15%	41
2017 Q3	$2.23M	Sell	78,289 -7,400	-9%	-$191K	0.17%	36
2017 Q2	$2.21M	Sell	85,689 -11,407	-12%	-$272K	0.28%	33
2017 Q1	$2.33M	Hold	97,096	–	–	0.3%	35
2016 Q4	$1.65M	Buy	97,096 +38,425	+65%	+$710K	0.33%	32
2016 Q3	$1.41M	Buy	58,671 +16,000	+37%	+$418K	0.25%	36
2016 Q2	$1.14M	Buy	42,671 +17,671	+71%	+$518K	0.25%	34
2016 Q1	$688K	Sell	25,000 -10,000	-29%	-$241K	0.24%	33
2015 Q4	$1.09M	Hold	35,000	–	–	0.37%	27
2015 Q3	$923K	Buy	35,000 +5,000	+17%	+$167K	0.24%	30
2015 Q2	$1.08M	Hold	30,000	–	–	0.3%	30
2015 Q1	$1.04M	Buy	+30,000	New	+$1.09M	0.4%	32

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors's CLLS Position: Q1 2018 in Review

Avoro Capital Advisors sold out of Cellectis (CLLS) in Q1 2018, closing a stake of 78,289 shares — an estimated $2.28M sold.

Avoro Capital Advisors first reported a position in CLLS in Q1 2015 and held it in 12 quarters. The position peaked at $2.33M in Q1 2017. 69 funds tracked by Wall St. Rank hold CLLS as of Q1 2018.

Avoro Capital Advisors reported no remaining Cellectis position as of Q1 2018 after selling out during the quarter.
Avoro Capital Advisors sold 78,289 Cellectis shares in Q1 2018, an estimated $2.28M.
Avoro Capital Advisors first reported a position in Cellectis in Q1 2015 and held it in 12 quarters.
Avoro Capital Advisors's Cellectis position peaked at $2.33M in Q1 2017.
69 funds tracked by Wall St. Rank held Cellectis as of Q1 2018.

Based on Avoro Capital Advisors's 13F filing for Q1 2018, filed 15 May 2018.